Resolving therapy resistance mechanisms in multiple myeloma by multiomics subclone analysisAlexandra M. Poos, Niels Weinhold, Nina Prokoph et al.|Blood|2023Cited by 62
Resolving the spatial architecture of myeloma and its microenvironment at the single-cell levelLukas John, Niels Weinhold, Nina Prokoph et al.|Nature Communications|2023Cited by 39
Bone marrow breakout lesions act as key sites for tumor-immune cell diversification in multiple myelomaRaphael Lutz, Niels Weinhold, Alexandra M. Poos et al.|Science Immunology|2025Cited by 23
Pre-Clinical Assessment of SAR442257, a CD38/CD3xCD28 Trispecific T Cell Engager in Treatment of Relapsed/Refractory Multiple MyelomaAnna Luise Grab, Marc S. Raab, Peter Kim et al.|Cells|2024Cited by 18
The biological and clinical impact of deletions before and after large chromosomal gains in multiple myelomaAnthony Cirrincione, Francesco Maura, Alexandra M. Poos et al.|Blood|2024Cited by 16